This finding suggested that PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to the etiology of NAFLD. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.